|
Volumn 3, Issue 5, 1998, Pages 314-318
|
Strategies for the use of epoetin alfa in breast cancer patients
|
Author keywords
Anemia; Anemia prevention; Breast; Erythropoietin; Phase III study; Review
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
CYCLOPHOSPHAMIDE;
EPIRUBICIN;
FLUOROURACIL;
GRANULOCYTE COLONY STIMULATING FACTOR;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
HEMOGLOBIN;
PLACEBO;
RECOMBINANT ERYTHROPOIETIN;
ANEMIA;
ARTICLE;
BLOOD TRANSFUSION;
BREAST CANCER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
|
EID: 17344362373
PISSN: 10837159
EISSN: None
Source Type: Journal
DOI: 10.1634/theoncologist.3-5-314 Document Type: Article |
Times cited : (7)
|
References (10)
|